Related Experiment Video
Updated: Jun 10, 2026
10:40
Adipose-Derived Mesenchymal Stromal Cells Co-Cultured with Primary Mixed Glia to Reduce Prion-Induced Inflammation
Published on: August 11, 2023
Immunotherapy for prion diseases: opportunities and obstacles
Li Li1, Scott Napper, Neil R Cashman
1University of British Columbia & Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
Immunotherapy
|July 20, 2010
Summary
Transmissible spongiform encephalopathies (TSEs) are unique infectious diseases caused by protein misfolding. Developing vaccines for TSEs is challenging but crucial for public health and other protein misfolding disorders.
Area of Science:
- Neuroscience
- Infectious Diseases
- Biochemistry
Background:
- Transmissible spongiform encephalopathies (TSEs) are infectious diseases caused by the misfolding of self-proteins into pathological conformations.
- Unlike other protein misfolding diseases, TSEs possess zoonotic potential and iatrogenic infectivity, highlighted by the bovine spongiform encephalopathy (BSE) outbreak.
- Concerns exist regarding asymptomatic carriers and the threat of animal TSEs to human health, alongside existing human prion diseases.
Purpose of the Study:
- To explore the potential of traditional medical approaches, specifically vaccines, for the treatment and prevention of TSEs.
- To address the challenges and dangers associated with inducing immune responses to self-epitopes in vaccine development for TSEs.
- To investigate the application of TSE research findings to other protein misfolding disorders.
Main Methods:
- Review of existing literature on TSEs and protein misfolding diseases.
- Analysis of challenges in vaccine development for self-protein-targeting immunotherapies.
- Exploration of immunotherapy and immunoprophylaxis strategies for chronic infections.
Main Results:
- TSEs present a unique infectious disease paradigm due to protein misfolding and zoonotic potential.
- Vaccine development for TSEs faces significant hurdles, including self-epitope immune responses and treating chronic infections.
- Despite challenges, TSE research offers insights applicable to broader protein misfolding disorders.
Conclusions:
- Effective treatment options for TSEs are necessary due to ongoing public health threats.
- Overcoming obstacles in TSE vaccine development is justified by the potential to impact human health and other protein misfolding conditions.
- Further research into immunotherapy and immunoprophylaxis for TSEs is warranted.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.